☆ 4.6 Article

Validation of no-biopsy pathway for the diagnosis of celiac disease in Asian adults: a multicenter retrospective study

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2023)

Related references

Note: Only part of the references are listed.

Review Biochemistry & Molecular Biology

Meta-Analysis and Systematic Review of HLA DQ2/DQ8 in Adults with Celiac Disease

Sara Aboulaghras et al.

Summary: Although HLA DQ2 and/or DQ8 genes increase the risk of developing celiac disease (CD), other factors such as genetics, the environment, and the immune system also play a role in the genesis of the disease. A comprehensive and meta-analytical study of adult CD patients was conducted to gain insight into the assessment and distribution of HLA class II (HLA-DQ2/DQ8) and explore screening techniques. DQ2/DQ2 homozygotes have the highest risk of developing CD, and DQ2/DQ8 typing is an effective test for differential diagnosis. The inclusion of non-HLA genes in diagnosis is limited due to their low contribution to the heritability of CD.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Gastroenterology & Hepatology

No-biopsy strategy for coeliac disease is applicable in adult patients: a 'real-world' Scottish experience

Aoisha Hoyle et al.

Summary: This study confirms that a no-biopsy strategy using a TGA-IgA cut-off of >=10x ULN is safe and reliable for diagnosing coeliac disease in adult patients, and no important pathology would be missed.

FRONTLINE GASTROENTEROLOGY (2023)

Add to Collection

Article Medical Laboratory Technology

Multicenter study to compare the diagnostic performance of CLIA vs. FEIA transglutaminase IgA assays for the diagnosis of celiac disease

Daan A. R. Castelijn et al.

Summary: This study compared the diagnostic performance of three tTG-IgA assay methods for the diagnosis of celiac disease. The results showed that the chemiluminescence immunoassays (CLIA) were more sensitive compared to the fluorescence enzyme-linked immunoassay (FEIA). Lowering the cut-off threshold of the FEIA improved its diagnostic accuracy in adult cases. There were also differences in tTG-IgA levels between different age groups of patients.

CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2023)

Add to Collection

Review Gastroenterology & Hepatology

The debate in the diagnosis of coeliac disease - time to go 'no-biopsy'?

Mohamed G. Shiha et al.

Summary: Recent studies suggest that duodenal biopsies may not be necessary for diagnosing coeliac disease in adults. However, certain patient groups still require duodenal biopsy sampling. If further guidelines adopt this approach, efforts should be made to facilitate communication between primary and secondary care for its appropriate implementation.

CURRENT OPINION IN GASTROENTEROLOGY (2023)

Add to Collection

Article Gastroenterology & Hepatology

Is duodenal biopsy always necessary for the diagnosis of coeliac disease in adult patients with high anti-tissue transglutaminase (TTG) antibody titres?

Junaid Beig et al.

Summary: The study aimed to evaluate the accuracy of using a cut-off value of >= 10 times the upper limit of normal for anti-TTG IgA titres for CD diagnosis in adult patients. Results showed that using anti-TTG IgA titres >= 10x normal value is a reliable predictor of CD in adult patients, suggesting that duodenal biopsy may not be necessary in selected cases.

FRONTLINE GASTROENTEROLOGY (2022)

Add to Collection

Review Gastroenterology & Hepatology

The global burden of coeliac disease: opportunities and challenges

Govind K. Makharia et al.

Summary: Despite advances in testing, awareness of coeliac disease remains suboptimal. This article summarizes the current knowledge and highlights research opportunities in epidemiology, risk factors, diagnosis and follow-up of coeliac disease. Challenges in diagnosis and management suggest opportunities for future research.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Gastroenterology & Hepatology

No-biopsy pathway following the interim BSG guidance reliably diagnoses adult coeliac disease

Richard David Johnston et al.

Summary: Recent guidance suggests a no-biopsy protocol for adults with high tTG-IgA titres, but this approach should only be used for selected patients and not all tTG-IgA positive patients.

FRONTLINE GASTROENTEROLOGY (2022)

Add to Collection

Letter Gastroenterology & Hepatology

Letter: the BSG COVID-19 interim coeliac disease guidance no-biopsy approach is safe in adults

Lina Bourhan Tashtoush et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Medicine, General & Internal

May Antitransglutaminase Levels Predict Severity of Duodenal Lesions in Adults with Celiac Disease?

Giuseppe Losurdo et al.

Summary: The study suggests that diagnostic criteria for celiac disease and villous atrophy based solely on serological markers are not reliable in adults. While high TGA levels are linked to villous atrophy, the sensitivity and specificity of this relationship are limited in adult patients.

MEDICINA-LITHUANIA (2021)

Add to Collection

Article Gastroenterology & Hepatology

Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult

Hugo A. Penny et al.

Summary: The study aimed to determine the predictive capacity and diagnostic yield of a 10-fold increase in serum IgA antitissue transglutaminase (tTG) antibody levels for detecting small intestinal injury diagnostic of coeliac disease (CD) in adult patients. Results showed that IgA tTG levels of >= 10xULN have a strong predictive value at identifying adults with intestinal changes diagnostic of CD, supporting the use of a no-biopsy approach for the diagnosis of adult CD.

GUT (2021)

Add to Collection

Letter Gastroenterology & Hepatology

Letter: no-biopsy pathway for diagnosing adult coeliac disease

Siba Prosad Paul et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Gastroenterology & Hepatology

European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020

Steffen Husby et al.

JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION (2020)

Add to Collection

Article Gastroenterology & Hepatology

Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study

Katri Lindfors et al.

GUT (2020)

Add to Collection

Article Nutrition & Dietetics

Non-Biopsy Serology-Based Diagnosis of Celiac Disease in Adults Is Accurate with Different Commercial Kits and Pre-Test Probabilities

Venla Ylonen et al.

NUTRIENTS (2020)

Add to Collection

Article Gastroenterology & Hepatology

Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities

Valma Fuchs et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Add to Collection

Review Gastroenterology & Hepatology

Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis

Prashant Singh et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Validation of Antibody-Based Strategies for Diagnosis of Pediatric Celiac Disease Without Biopsy

Johannes Wolf et al.

GASTROENTEROLOGY (2017)

Add to Collection

Article Gastroenterology & Hepatology

Titers of Anti-tissue Transglutaminase Antibody Correlate Well With Severity of Villous Abnormalities in Celiac Disease

Prashant Singh et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Comparison of Commercially Available Serologic Kits for the Detection of Celiac Disease

Afzal J. Naiyer et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2009)

Add to Collection

© Peeref 2019-2024. All rights reserved.